CCL4 is a ligand for CCR5, a chemokine receptor on macrophages, microglia, and T cells, and CCR5 was recently shown to be a promising target to ameliorate TBI and stroke suggesting that less of these cells may be beneficial to TBI (Joy et al., 2019). Here, CCR5 is linked to stroke disorder.